Litcius/Paper detail

Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma

Niloofar Ayoobi Yazdi, Mohammad-Mehdi Mehrabinejad, Habibollah Dashti, Ramin Pourghorban, Mohssen Nassiri Toosi, Hadi Rokni Yazdi

2021Radiology29 citationsDOI

Abstract

< .001 for both). No major complications were detected. Conclusion Percutaneous sclerotherapy is a safe and feasible method with promising results in the treatment of patients with symptomatic giant liver hemangioma. Clinical trial registration no. NCT03649113 © RSNA, 2021 See also the editorial by McGahan and Goldman in this issue.

Topics & Concepts

MedicineSclerotherapyPercutaneousHemangiomaBleomycinRadiologyVisual analogue scaleSurgeryInterventional radiologyPolidocanolVenous malformationChemotherapyVascular Malformations and HemangiomasVascular Tumors and AngiosarcomasGenetic and Kidney Cyst Diseases
Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma | Litcius